Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Tilly
H
H
Department of Hematology, Centre Henri Becquerel, Rouen, France.
Dreyling
M
M
D018951:Antigens, CD20 / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018826:CD13 Antigens / Q000378:metabolism; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D017493:Leukocyte Common Antigens / Q000378:metabolism; D016393:Lymphoma, B-Cell / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy*; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D055502:Secondary Prevention; D016896:Treatment Outcome
D018951:Antigens, CD20; D017493:Leukocyte Common Antigens; D018826:CD13 Antigens